Angelo J. Canty

Nature Medicine · 2002–2015

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Whom Angelo J. Canty trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bernard Walter Silverman
  2. Emanuel Parzen
  3. Tim Hesterberg

Who trusts Angelo J. Canty overall

  1. Jonathan Z. Bakdash
  2. Alexandre Leblanc
  3. P. Wargocki
  4. Yoshihide Kakizawa
  5. Laura R. Marusich
  6. G. Babu
  7. Kai-Cheng Yang

Papers from Angelo J. Canty's perspective

Ordered by how strongly the researchers Angelo J. Canty trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Weighted Average Importance Sampling and Defensive Mixture Distributions
  2. Remarks on Some Nonparametric Estimates of a Density Function
  3. On Estimation of a Probability Density Function and Mode
  4. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments (Statistical Applications in Genetics and Molecular Biology)
  5. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). (Blood)
  6. Disruption of differentiation in human cancer: AML shows the way (Nature Reviews. Cancer)
  7. Prognostically useful gene-expression profiles in acute myeloid leukemia. (New England Journal of Medicine)
  8. The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche (Cell Stem Cell)
  9. The Increasing Complexity of the Cancer Stem Cell Paradigm (Science)
  10. A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy. (Blood)

Their papers